The global surgical sutures market is valued at USD 4.84 billion in 2024, expected to grow to USD 5.09 billion in 2025, and projected to reach around USD 7.96 billion by 2034, expanding at a CAGR of 5.14% (2025–2034). North America dominates with 45% share (2024), while Asia Pacific is projected to grow fastest. Absorbable sutures and multifilament sutures lead the type and filament categories, while cardiovascular surgery dominates application, and orthopedic surgery grows fastest. Growth is driven by an aging population, increasing chronic diseases, and technological innovations such as antimicrobial and biodegradable sutures.
Download the free sample and get the complete insights and forecasts report on this market @ https://www.towardshealthcare.com/download-sample/5655
◉2024 Market Value → USD 4.84 billion.
◉2025 Market Value → USD 5.09 billion, showing short-term steady growth.
◉2034 Projected Value → USD 7.96 billion.
◉CAGR (2025–2034) → 5.14%, moderate but steady expansion.
◉Regional Leader (2024) → North America held 45% market share, driven by advanced infrastructure.
◉Fastest Growing Region → Asia Pacific, due to aging populations in China & India, plus chronic disease prevalence.
◉Segment Leaders (2024) →
◉Absorbable sutures (by type).
◉Multifilament sutures (by filament).
◉Cardiovascular surgery (by application, dominance).
◉Orthopedic surgery (fastest growth application).
◉Feb 2025: Indian government invested Rs. 6.5 Cr into technical textiles for workforce development → boosts advanced suture manufacturing.
◉Mar 2024: Mankind partnered with Healthium Medtech to compete in surgical supplies.
◉AI optimizes suture quality, enhances minimally invasive surgery outcomes.
◉Robotics enhances precision in suturing.
◉Shift towards biodegradable, bioabsorbable, and antimicrobial sutures to reduce infection risk.
◉Rising demand for sutures designed for tiny incisions and faster healing.
◉Latin America & Asia-Pacific attract global patients due to affordability → more surgical procedures → higher suture demand.
◉AI improves production efficiency, reduces waste, enhances material consistency.
◉Machine learning algorithms help design stronger, flexible, antimicrobial sutures tailored for different surgeries.
◉Real-time defect detection in suture production through computer vision systems.
◉Predictive AI tools forecast demand by region & application, reducing stock shortages.
◉AI helps design patient-specific sutures, especially for minimally invasive and robotic surgeries.
◉AI + robotics improve precision, speed, and safety in cardiovascular & orthopedic surgeries.
◉AI reduces downtime in suture production facilities.
◉Automation powered by AI lowers operational costs, making advanced sutures more affordable.
Driver: Highly developed healthcare infrastructure
◉North America’s dominance is rooted in its state-of-the-art hospital networks, high surgical volumes, and wide adoption of advanced suturing techniques. The U.S. and Canada collectively account for a large portion of global surgical procedures due to aging demographics and high chronic disease prevalence.
U.S.
◉The U.S. represents the largest share in North America due to the high prevalence of cardiovascular conditions, orthopedic injuries, and cancer surgeries.
◉Cardiovascular diseases remain the #1 cause of death in the U.S., leading to thousands of open-heart and bypass surgeries annually, all requiring advanced sutures.
◉The aging population (65+ years) undergoes joint replacements, fracture repairs, and cancer-related surgeries at a higher rate → sustained suture demand.
◉High adoption of robotic-assisted and minimally invasive surgeries has boosted demand for specialized sutures that support small incisions and faster healing.
Canada
◉Focus is shifting toward safer, antimicrobial, and absorbable sutures to reduce infection risk, given the healthcare system’s strong emphasis on patient safety.
◉Canada’s government support for medical innovation has spurred research into next-gen suture materials.
◉Expanding access to advanced surgical care in rural regions further increases the demand for sutures.
Driver: Aging population + rising chronic diseases
◉Asia Pacific is undergoing demographic transformation with large elderly populations in China, Japan, and India. This, coupled with rising cancer, diabetes, and cardiovascular cases, directly increases the volume of surgical procedures.
China
◉Innovation Hub → Chinese researchers are increasingly focusing on next-gen sutures.
◉Example: Oct 2024 – Biodegradable suture with self-electrification to stimulate healing → represents the global trend toward “active sutures” that enhance wound healing.
◉China’s dual strategy: Expand local manufacturing for affordability + invest in advanced bioengineering for global competitiveness.
◉Rapid adoption of robotic-assisted surgeries in tier-1 cities (Beijing, Shanghai) → boosts demand for precision sutures.
India
◉Healthcare system is witnessing surge in surgeries, both from aging citizens and younger demographics due to sports injuries & trauma cases.
◉Aug 2023: Healthium Medtech launched TRUMAS™ sutures, tailored for minimal access surgeries → addresses India’s rising laparoscopic surgery trend.
◉India also benefits from medical tourism (affordable surgeries for patients from Africa, Middle East, and South Asia), further increasing suture usage.
◉Strong government backing for domestic production makes India a future hub for surgical sutures export.
◉Driver: Rising healthcare investments & focus on quality care
Europe’s market growth is driven by government-funded healthcare systems, regulatory emphasis on patient safety, and adoption of innovative medical devices.
Germany
◉One of the largest aging populations in Europe, driving demand for joint replacements, cardiac surgeries, and cancer-related procedures.
◉German hospitals are at the forefront of using biodegradable sutures with antimicrobial coatings to reduce post-op infections.
◉Heavy focus on orthopedic surgery due to high arthritis and fracture incidences in the elderly.
UK
◉Shift toward biodegradable, antimicrobial sutures to reduce hospital stays and complications.
◉Single-use suturing devices are increasingly adopted in NHS hospitals → reduces infection risk and speeds up surgical workflows.
◉Heavy investment in robotic-assisted minimally invasive surgeries (especially in London and other advanced centers) is driving the adoption of specialized sutures.
◉Driver: Medical tourism + affordability
Latin America is emerging as a surgical tourism hotspot, especially for cosmetic surgeries, orthopedics, and cardiovascular procedures. Lower costs and skilled surgeons attract international patients, directly expanding suture demand.
Mexico
◉Attracts 1.2M foreign patients annually, largely from the U.S. due to geographical proximity and cost advantages.
◉Leading local players: Atramat, Sutumed Corp, Coats Group → supply both local and international hospitals.
◉Cosmetic and bariatric surgeries are common, requiring specialized sutures with aesthetic outcomes.
Brazil
◉Home to over 6,500 hospitals, Brazil has the largest healthcare network in Latin America.
◉Global leader in cosmetic surgeries (breast augmentations, facelifts, liposuctions), making it a top suture consumer.
◉Local manufacturers (e.g., Bioline, MZF4 Medical) ensure domestic availability of sutures and reduce dependence on imports.
◉Brazil’s medical tourism sector attracts thousands of international patients each year, boosting surgical volumes.
◉Driver: Expanding healthcare infrastructure
Rapid modernization of healthcare in GCC countries and parts of Africa is increasing adoption of advanced surgical sutures.
UAE & Saudi Arabia
◉Heavy state funding into building world-class hospitals (Dubai, Riyadh) → ensures rising surgical volumes.
◉Growing prevalence of lifestyle-related diseases (obesity, diabetes) → more bariatric and cardiovascular surgeries.
◉Governments are partnering with international medtech companies to supply high-quality sutures.
South Africa
◉Healthcare sector still developing, but adoption of modern wound closure techniques is rising.
◉Increasing prevalence of trauma-related surgeries due to road accidents and violence → driving demand for durable sutures.
◉Growing private healthcare sector is boosting advanced surgical practices.
◉Aging population → Higher susceptibility to chronic illnesses (cancer, diabetes, cardiovascular diseases).
◉Rising surgical procedures → More joint replacements, heart surgeries, cancer surgeries, trauma repairs.
◉Technological advances → Antimicrobial, biodegradable sutures, robotic-assisted surgeries.
◉Alternatives: Staples, tissue adhesives, and hemostats replace sutures in selected surgeries.
◉Advanced wound care products: Foam & hydrocolloid dressings reduce need for suturing in superficial wounds.
◉Minimally Invasive Surgeries (MIPs) → Growing globally, requiring specialized fine sutures.
◉Innovative materials → Biodegradable, antimicrobial sutures → reduce infections, improve healing, and appeal to healthcare providers.
◉Products: Absorbable & non-absorbable sutures (Vicryl, Monosyn).
◉Strength: Strong global supply chain, wide surgical portfolio, R&D leadership in bioresorbable materials.
◉Products: Monocryl, Vicryl, Ethibond.
◉Strength: Market leader, extensive surgeon loyalty, pioneering role in laparoscopic surgery sutures.
◉Products: High-strength cardiovascular & orthopedic sutures.
◉Strength: Integration with robotic surgery platforms, making sutures compatible with advanced techniques.
◉Products: Orthopedic & wound management sutures.
◉Strength: Specialist in orthopedics and sports medicine, leveraging minimally invasive solutions.
◉Products: TRUMAS™, barbed sutures, minimally invasive solutions.
◉Strength: Rising global presence, innovation focus, Asia-Pacific cost advantage.
◉Products: Surgical sutures, catheterization devices.
◉Strength: Strong U.S. hospital network, bundled product offerings.
◉Products: Ophthalmic & cardiovascular microsutures.
◉Strength: Focus on high-precision microsurgery sutures, niche innovation.
◉Products: Ophthalmic, specialty absorbable sutures.
◉Strength: Cost-efficient emerging player, expanding presence in domestic and international markets.
◉India → Rs. 6.5 Cr investment in technical textiles supports workforce training in suture & medtech manufacturing.
◉U.S. → Medicare & Medicaid reimbursement policies encourage surgeries, indirectly supporting high suture usage.
◉EU → Medical Device Regulation (MDR) enforces strict safety & quality compliance → fosters adoption of high-standard sutures.
◉China → Government promotes domestic R&D for biodegradable sutures → reduces dependency on imports.
◉Middle East → Saudi Arabia & UAE investing billions in hospital infrastructure, importing advanced surgical sutures.
◉North America → High-volume automated production with robotics and AI in factories, ensuring consistent quality.
◉Asia Pacific → India & China as low-cost, high-volume production hubs → growing exports globally.
◉Europe → Focused on premium-quality sutures, regulated under EU MDR, less cost-sensitive.
◉Latin America → Regional companies supply both domestic hospitals and export markets; strong in ophthalmic & cosmetic sutures.
◉MEA → Production still limited; reliance on imports from India, EU, and U.S., but new facilities are emerging.
Absorbable Sutures
Collagen-based sutures
◉Derived from natural sources (catgut, bovine, or porcine origin).
◉Commonly used in soft tissue repair, oral surgeries, and gynecology.
◉ Limitation: Inconsistent absorption rates, risk of inflammation.
Synthetic polymer-based sutures
◉Polyglycolic acid (PGA), Polyglactin 910 (Vicryl), Polydioxanone (PDS), Polyglyconate.
◉Provide predictable absorption and higher tensile strength than natural collagen.
◉Preferred in cardiovascular, gastrointestinal, and pediatric surgeries.
Biodegradable sutures (advanced category)
◉Engineered with antimicrobial coatings, drug-eluting properties, or bioactive materials.
◉Example: China, Oct 2024 → Electric-stimulation biodegradable suture for wound healing acceleration.
◉Growing focus in minimally invasive surgeries due to reduced need for removal.
Non-Absorbable Sutures
Nylon
◉Widely used for skin closure, ophthalmology, and neurosurgery.
◉High tensile strength, low tissue reactivity.
Silk
◉Traditional, easy handling, knot security.
◉Still used in cardiovascular and GI surgeries despite gradual replacement by synthetics.
Polyester (e.g., Ethibond)
◉High durability and strength.
◉Ideal for orthopedic, cardiovascular, and valve replacement surgeries.
Polypropylene & Stainless Steel
◉Polypropylene: Low tissue reactivity, used in cardiovascular grafts and hernia repair.
◉Stainless steel: Used in sternum closure, orthopedic fixation, trauma repair.
Monofilament Sutures
◉Single smooth strand → minimal tissue drag and reduced infection risk.
◉Slower knot security compared to braided sutures, requiring skilled handling.
◉Commonly used in cardiovascular, ophthalmic, and plastic surgeries where precision matters.
◉Example: Polypropylene (Prolene) used in hernia mesh fixation and vascular procedures.
Multifilament Sutures (Braided)
◉Multiple filaments braided together for superior strength and flexibility.
◉Easier handling, knot security, but higher risk of bacterial colonization.
◉Widely used in orthopedic, GI, and general surgeries where durability is crucial.
◉Example: Polyglactin 910 (Vicryl) – gold standard for soft tissue approximation.
Ophthalmic
◉Requires extremely fine sutures (10-0, 11-0 nylon or polypropylene).
◉Used in corneal transplants, cataract extraction, and glaucoma surgeries.
◉Demand driven by rising prevalence of cataracts, especially in Asia & aging populations.
◉Example: Surgical Specialties Corporation and Dolphin Sutures specialize in ophthalmic sutures.
Cardiovascular
◉High-strength, non-absorbable and absorbable sutures required for vessel anastomosis, valve repair, bypass grafting.
◉Polypropylene, polyester, and PTFE are common choices due to durability.
◉Growth fueled by rising prevalence of cardiovascular diseases (CVDs) and increase in surgical procedures like CABG.
Orthopedic
◉Heavy-duty sutures required for tendon, ligament, and bone fixation.
◉Multifilament polyester or ultra-high-molecular-weight polyethylene (UHMWPE) used in sports medicine and joint reconstruction.
◉Example: Smith & Nephew and Medtronic dominate orthopedic sutures market with integration into surgical anchors and robotics.
Neurological
◉Requires precision suturing with minimal tissue trauma.
◉Monofilament polypropylene or nylon used for dura mater repair, nerve repair, cranial closure.
◉Growing demand with rising neurosurgeries for tumors, trauma, and spinal disorders.
Others
◉Dental surgeries – absorbable sutures (collagen, PGA) for oral wound closure.
◉Gynecology/Obstetrics – absorbable sutures for C-sections, episiotomies, hysterectomy.
◉Gastrointestinal – sutures for anastomosis, bowel closure, liver and pancreas surgeries.
◉Plastic & Reconstructive surgeries – fine absorbable sutures for aesthetics and wound healing.
North America
◉Mature market with advanced surgical practices.
◉High adoption of robotic-assisted surgeries driving demand for compatible sutures.
◉Medicare/Medicaid reimbursements support high suture usage in elderly care.
Europe
◉Stringent EU MDR regulations → focus on safe, high-quality sutures.
◉Rising preference for antimicrobial & biodegradable sutures to reduce post-op complications.
◉Germany and UK lead in surgical innovations, especially in orthopedics and ophthalmology.
Asia Pacific
◉Fastest growing market due to aging population, chronic disease burden, and expanding surgical volumes.
◉India emerging as cost-efficient manufacturing hub (Healthium Medtech, Dolphin Sutures).
◉China focusing on domestic innovation in biodegradable & smart sutures.
Latin America
◉Growing due to medical tourism (Mexico, Brazil).
◉Mexico attracts 1.2M foreign patients annually seeking cost-effective surgeries.
◉Brazil’s large hospital base fuels demand, with Atramat and Bioline as strong local players.
Middle East & Africa (MEA)
◉UAE & Saudi Arabia: Heavy investments in surgical infrastructure and advanced devices.
◉South Africa: Increasing adoption of modern wound closure techniques.
◉Market still import-dependent but gradually developing local manufacturing hubs.
Q1. What is the market size of surgical sutures in 2025?
A1. The global surgical sutures market is valued at USD 5.09 billion in 2025, driven by rising surgical procedures and chronic disease prevalence.
Q2. What is the forecasted market size by 2034?
A2. The market is projected to reach USD 7.96 billion by 2034, supported by innovations in biodegradable and antimicrobial sutures.
Q3. Which region dominates the market?
A3. North America leads with a 45% share (2024), owing to advanced healthcare infrastructure and high surgical volumes.
Q4. Which type of sutures leads the market?
A4. Absorbable sutures dominate, offering predictable healing and strong adoption in minimally invasive surgeries.
Q5. Which region is expected to grow fastest?
A5. Asia Pacific is the fastest-growing market, fueled by an aging population, chronic diseases, and rising surgical procedures.
Access our exclusive, data-rich dashboard dedicated to the therapeutic area – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5655
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
Web: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
The global nootropics market size reached USD 5.71 billion in 2025 and is projected to grow to USD 19.53 billion… Read More
The U.S. concierge medicine market was valued at USD 7.25 billion in 2024, grew to USD 8 billion in 2025,… Read More
The global recombinant proteins market is valued at USD 3.36 billion in 2025 and projected to reach USD 8.08 billion… Read More
The global digital biomarkers market was valued at USD 5.09 billion in 2025 and is projected to reach USD 32.37… Read More
The global chemotherapy market is estimated at USD 10.28 billion in 2025 and projected to reach USD 19.35 billion by… Read More
The global endoscopy devices market was valued at USD 61.1 billion in 2024, increased to USD 63.44 billion in 2025,… Read More